Effect of Nutritional Regulation on Adipokines in Obesity: A Review

Mansi Chopra^1, , Anupa Siddhu¹ and Nikhil Tandon²

¹Department of Food and Nutrition, Lady Irwin College, Sikandra Road, New Delhi, University of Delhi, India

²Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India

Cite this paper:
Mansi Chopra, Anupa Siddhu and Nikhil Tandon. Effect of Nutritional Regulation on Adipokines in Obesity: A Review. American Journal of Food and Nutrition. 2014; 2(4):66-70. doi: 10.12691/ajfn-2-4-4

Abstract

Childhood obesity has become a major public health problem worldwide and it increases the risk of developing severe obesity, coronary heart disease, type 2 diabetes and respiratory disease in adulthood. Low grade inflammation has been identified as a key factor in development of obesity. In obesity, the expanding adipose tissue makes a substantial contribution to the development of obesity-linked inflammation via dysregulated secretion of pro-inflammatory cytokines, chemokines and adipokines and the reduction of anti-inflammatory adipokines, such as adiponectin. The macronutrient composition of the diet regulates the overall body weight and metabolism and caloric intake is one of the major contributors to obesity, where certain kinds of diet (pro-inflammatory) can promote obesity, and other kinds (anti-inflammatory) can reduce it. Lifestyle interventions like caloric restriction and increases in physical activity can lead to weight control which induce attenuation of obesity-induced inflammatory responses, which is a risk factor for obesity related chronic diseases, along with a decrease in fat mass in obesity.

Keywords:
nutritional regulation obesity adipokines macronutrients inflammation

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	World Health Organization, “Preventing and managing the global epidemic,” Report of a WHO consultation: World Health Organ Tech Rep Series 894(i–xii), 1-253, 2000.
[2]	Hedley, A.A., Ogden, C.L., Johnson, C.L., Carroll, M.D., Curtin, L.R. and Flegal, K.M, “Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002,” JAMA 291. 2847-2850. 2004.
[3]	Zimmermann, M.B., Gubeli, C., Puntener, C. and Molinari, L, “Overweight and obesity in 6-12 year old children in Switzerland,” Swiss Medicine Weekly 134. 523-528. 2004.
[4]	Ferraro, K.F., Thorpe, R.J. Jr. and Wilkinson JA, “The life course of severe obesity: does childhood overweight matter?” J Gerontol B Psychol Sci Soc Sci 58. S110-S119. 2003.
[5]	Dietz, W.H, “Health consequences of obesity in youth: childhood predictors of adult disease,” Pediatrics 101. 518-25. 1998.
[6]	Power, C., Lake, J.K. and Cole, T.J, “Measurement and long-term health risks of child and adolescent fatness,” Int J Obes Relat Metab Disord 21. 507-26. 1997.
[7]	Murer, S.B., Kno¨pfli, B.H., Aeberli, I, et al. “Baseline leptin and leptin reduction predict improvements in metabolic variables and long-term fat loss in obese children and adolescents: a prospective study of an inpatient weight-loss program,” Am J Clin Nutr 93. 695-702. 2011.
[8]	So, M., Gaidhu, M.P., Maghdoori, B. and Ceddia, R.B, “Analysis of time-dependent adaptations in whole body energy balance in obesity induced by high fat diet in rats,” Lipids in Health and Disease 10. 99. 2011.
[9]	Sun, X. and Zemel, M.B, “Calcium and 1,25 Dihydroxyvitamin D3 Regulation of Adipokine Expression,” Obesity 15. 2. 2007.
[10]	Flatt, J.P, “Use and storage of carbohydrate and fat,” Am J Clin Nutr 61. 952S-959S. 1995.
[11]	Flatt, J.P., Ravussin, E., Acheson, K.J. and Jequier, E, “Effects of dietary fat on postprandial substrate oxidation and on carbohydrate and fat balances,” J Clin Invest 76. 1019-1024. 1985.
[12]	Prentice, A.M, “Manipulation of dietary fat and energy density and subsequent effects on substrate flux and food intake,” Am J Clin Nutr 67. 535S-541S. 1998.
[13]	Pereira-Lancha, L.O., Coelho, D.F., Lopes de Campos-Ferraz, P. and Lancha, Jr. A.H, “Body Fat Regulation: Is It a Result of a Simple Energy Balance or a High Fat Intake?” Journal of the American College of Nutrition 29(4). 343-351. 2010.
[14]	Bray, G.A., Paeratakul, S. and Popkin, B.M, “Dietary fat and obesity: a review of animal, clinical and epidemiological studies,” Physiology and Behavior 83. 549-555. 2004.
[15]	Tome, D, “Protein, amino acids and the control of food intake,’’ British Journal of Nutrition 92, S27-S30. 2004.
[16]	Levin, B.E, “Factors promoting and ameliorating the development of obesity,” Physiology and Behavior 86. 633-639. 2005.
[17]	Beck, B. and Richy, S, “Differential long-term dietary regulation of adipokines, ghrelin, or corticosterone: impact on adiposity,” J of Endocrinol 196. 171-179. 2008.
[18]	Aggarwal, B.B. and Shishodia, S, “Molecular targets of dietary agents for prevention and therapy of cancer,” Biochem Pharmacol 71. 1397-1421. 2006.
[19]	Ghanim, H., Garg, R. and Aljada, A, et al. “Suppression of nuclear factor kappa B and stimulation of inhibitor kappa B by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese,” J Clin Endocrinol Metab 86. 1306-1312. 2001.
[20]	Lamas, O., Moreno-Aliaga, M.J., Martinez, J.A. and Marti, A, “NF-kappa B-binding activity in an animal diet-induced overweightness model and the impact of subsequent energy restriction,” Biochem Biophys Res Commun 311. 533-539. 2003.
[21]	Navab, M., Gharavi, N. and Watson, A.D, “Inflammation and metabolic disorders,” Curr Opin Clin Nutr Metab Care 11. 459-464. 2008.
[22]	Rajala, M.W. and Scherer, P.E, “Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis,” Endocrinol 144. 3765-3773. 2003.
[23]	Fontana, L., Klein, S. and Holloszy, J.O, “Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production,” Age (Dordr) 32(1). 97-108. 2010.
[24]	Reeds, D.N, “Nutrition support in the obese, diabetic patient: the role of hypocaloric feeding,” Curr Opin Gastroenterol 25. 151–154. 2009.
[25]	Varady, K.A. and Hellerstein, M.K, “Do calorie restriction or alternate-day fasting regimens modulate adipose tissue physiology in a way that reduces chronic disease risk?” Nutr Rev 66. 333-342. 2008.
[26]	Aggarwal, B.B, “Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals,” Annu Rev Nutr 21(30). 173-199. 2010.
[27]	Yannakoulia, M., Yiannakouris, N., Bluher, S., Matalas, A.L., Zacas, D.K. and Mantzoros, C.S, “Body Fat Mass and Macronutrient Intake in Relation to Circulating Soluble Leptin Receptor, Free Leptin Index, Adiponectin, and Resistin Concentrations in Healthy Humans,” J Clin Endocrinol Metab 88(4). 1730-1736. 2003.
[28]	Weigle, D.S., Duell, P.B., Connor, W.E., Steiner, R.A., Soules, M.R. and Kuijper, J.L, “Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels,” J Clin Endocrinol Metab 82. 561-565. 1997.
[29]	Wisse, B.E., Campfield, L.A., Marliss, E.B., Morais, J.A., Tenenbaum, R. and Gougeon. R, “Effects of prolonged moderate and severe energy restriction and refeeding on plasma leptin concentrations in obese women,” AJCN 70. 321-330. 1999.
[30]	Kolaczynski, J.W., Considine, R.V. and Ohannesian, J, et al. “Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves,” Diab 45. 1511-1515. 1996.
[31]	Kolaczynski, J.W., Ohannesian, J.P., Considine, R.V., Marco, C.C. and Caro, J.F, “Response of leptin to short-term and prolonged overfeeding in humans,” J Clin Endocrinol Metab 81. 4162-4165. 1996.
[32]	Spruijt-Metz, D., Belcher, B. and Anderson, D, et al. “A high sugar, low fiber meal leads to higher leptin and physical activity levels in overweight Latina females as opposed to a low sugar, high fiber meal,” J Am Diet Assoc 109(6). 1058-1063. 2009.
[33]	Lovejoy, J.C., Windhauser, M.M., Rood, J.C. and de la, Bretonne, J.A, “Effect of a controlled high-fat versus low-fat diet on insulin sensitivity and leptin concentration in African-American and Caucasian women,” Metab 47. 1520-1524. 1998.
[34]	Chu, N.F., Stampfer, M.J., Spiegelman, D., Rifai, N., Hotamisligil, G.S. and Rimm, E.B, “Dietary and lifestyle factors in relation to serum leptin concentrations among normal weight and overweight men,” Int J Obes 25. 106-114. 2001.
[35]	Thompson, F.E. and Byers, T, “Dietary assessment resource manual,” J of Nutr 124. 2245S-2317S. 1994.
[36]	Cammisotto, P.G., Gelinas, Y., Deshaies, Y. and Bukowiecki, L.J, “Regulation of leptin secretion from white adipocytes by free fatty acids,” Am J Physiol Endocrinol Metab 285. E521-E526. 2003.
[37]	Kratz, M., von Eckardstein, A. and Fobker, M, et al. “The impact of dietary fat composition on serum leptin concentrations in healthy nonobese men and women,” J Clin Endocrinol Metab 87. 5008-5014. 2002.
[38]	Peyron-Caso. E., Taverna, M. and Guerre-Millo, M, et al. “Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulinresistant rats,” J Nutr 132. 2235-2240. 2002.
[39]	Reseland, J.E., Haugen, F. and Hollung, K, et al. “Reduction of leptin gene expression by dietary polyunsaturated fatty acids,” J Lipid Res 42. 743-750. 2001.
[40]	Winnicki, M., Somers, V.K. and Accurso, V, et al. “Fish-rich diet, leptin, and body mass,” Circulation 106. 289-291. 2002.
[41]	Penumetcha, M., Merchant, N. and Parthasarathy, S, “Modulation of Leptin Levels by Oxidized Linoleic Acid: A Connection to Atherosclerosis?” J Med Food 14(4). 441-443. 2011.
[42]	Tschop, M., Weyer, C., Tataranni, P.A., Devanarayan, V., Ravussin, E. and Heiman, M.L, “Circulating ghrelin levels are decreased in human obesity,” Diab 50. 707–709. 2001.
[43]	Awada, M., Meynier, A. and Soulage, C.O, et al. “n-3 PUFA added to high-fat diets affect differently adiposity and inflammation when carried by phospholipids or triacylglycerols in mice,” Nutr Metab 10. 23. 2013.
[44]	Moreno-Aliaga, M.J., Lorente-Cebria´n, S. and Alfredo Martı´nez, J, “Fatty acids and the immune system Regulation of adipokine secretion by n-3 fatty acids,” Proceedings of the Nutrition Society 69. 324-332. 2010.
[45]	Peyron-Caso, E., Taverna, M. and Guerre-Millo, M, et al. “Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulin-resistant rats,” J Nutr 132. 2235-2240. 2002.
[46]	Rossi, A.S., Lombardo, Y.B. and Lacorte, J.M, et al. “Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats”. Am J Physiol Regul Integr Comp Physiol 289. R486-R494. 2005.
[47]	Matsuzawa, Y., Funahashi, T., Kihara, S. Shimomura, I, “Adiponectin and metabolic syndrome,” Arteriosclerosis, Thrombosis and Vascular Biology 24(1). 29-33. 2004.
[48]	Weyer, C., Funahashi, T. and Tanaka, S, et al. “Hypoadiponectiemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia,” J Clin Endocrinol Metab 86. 1930-1935. 2001.
[49]	Wang, Z. and Nakayama, T, “Inflammation, a Link between Obesity and Cardiovascular Disease,” Mediators of Inflammation 1155-1172. 2010.
[50]	Havel, P.J, “Regulation of Energy Balance and Carbohydrate /Lipid Metabolism,” Diab 53. 2004.
[51]	Kazumi, T., Kawaguchi, A., Sakai, K., Hirano, T. amd Yoshino, G, “Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure,” Diab Care 25:971–976. 2002.
[52]	Fruebis, J., Tsao, T.S. and Javorschi, S, “Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice,” Proc Natl Acad Sci 98. 2005-2010. 2001.
[53]	Flachs, P., Mohamed-Ali, V. and Horakova, O, et al. “Polyunsaturated fatty acids of marine origin induceadiponectin in mice fed a high-fat diet,” Diabetologia 49, 394-397. 2006.
[54]	Gonzalez-Periz, A., Horrillo, R. and Ferre, N, et al. “Obesity induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins,” FASEB J 23. 1946-1957. 2009.
[55]	Neschen, S., Morino, K. and Rossbacher, J.C, et al. “Fish oil regulates adiponectin secretion by a peroxisome proliferator- activated receptor-gamma-dependent mechanism in mice,” Diab 55. 924-928. 2006.
[56]	Zemel, M.B. and Sun, X, “Dietary Calcium and Dairy Products Modulate Oxidative and Inflammatory Stress in Mice and Humans,” J Nutr 2008.
[57]	Haseeb, A., Iliyas, M. and Chakrabarti, S, et al. “Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor gamma and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population,” J Biosciences 34(3). 405-414. 2009.
[58]	Va´zquez, M.J., Gonza´ lez, C.R. and Varela, L, et al. “Central Resistin Regulates Hypothalamic and Peripheral Lipid Metabolism in a Nutritional-Dependent Fashion,” Endocrinol 149(9s). 4534-4543. 2008.